<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>OBJECTIVES: To investigate IgG, IgM, and IgA, <z:hpo ids='HP_0003613'>antiphospholipid antibodies</z:hpo> (aPL), against <z:chebi fb="0" ids="28494">cardiolipin</z:chebi> (aCL), beta(2)-<z:chebi fb="2" ids="17089">glycoprotein</z:chebi> I (anti-beta(2)GPI), and prothrombin (anti-PT), in black South African patients with <z:e sem="disease" ids="C0009450" disease_type="Disease or Syndrome" abbrv="">infectious disease</z:e> </plain></SENT>
<SENT sid="1" pm="."><plain>Unlike patients with <z:hpo ids='HP_0002725'>systemic lupus erythematosus</z:hpo> (SLE) and the <z:e sem="disease" ids="C0085278" disease_type="Disease or Syndrome" abbrv="">antiphospholipid syndrome</z:e> (APS), raised levels of aPL in <z:e sem="disease" ids="C0009450" disease_type="Disease or Syndrome" abbrv="">infectious diseases</z:e> are not usually associated with thrombotic complications </plain></SENT>
<SENT sid="2" pm="."><plain>PATIENTS AND METHODS: Serum samples from 272 patients with a variety of <z:e sem="disease" ids="C0009450" disease_type="Disease or Syndrome" abbrv="">infectious diseases</z:e> (100 HIV positive, 112 leprosy, 25 syphilis, 25 malaria, and 10 HCV patients) were studied and compared with autoantibody levels in 100 <z:mpath ids='MPATH_458'>normal</z:mpath> controls </plain></SENT>
<SENT sid="3" pm="."><plain><z:hpo ids='HP_0000001'>All</z:hpo> three aPL were measured using commercial enzyme linked immunosorbent assay (ELISA) kits </plain></SENT>
<SENT sid="4" pm="."><plain>RESULTS: Raised levels of <z:hpo ids='HP_0000001'>all</z:hpo> three aPL were found in <z:hpo ids='HP_0000001'>all</z:hpo> patient groups studied: aCL in 7%, anti-beta(2)GPI in 6%, and aPT in 43% of 100 HIV patients, in 29%, 89%, and 21% of 112 patients with <z:e sem="disease" ids="C0023343" disease_type="Disease or Syndrome" abbrv="">leprosy</z:e>, in 8%, 8%, and 28% of 25 patients with <z:e sem="disease" ids="C0039128" disease_type="Disease or Syndrome" abbrv="">syphilis</z:e>, in 12%, 8%, and 28% of 25 patients with <z:e sem="disease" ids="C0024530" disease_type="Disease or Syndrome" abbrv="">malaria</z:e>, and in 20%, 30%, and 30% of 10 HCV patients studied, respectively </plain></SENT>
<SENT sid="5" pm="."><plain>CONCLUSIONS: The prevalence of aCL and anti-beta(2)GPI in black South African HIV positive patients, or those with <z:e sem="disease" ids="C0039128" disease_type="Disease or Syndrome" abbrv="">syphilis</z:e>, <z:e sem="disease" ids="C0024530" disease_type="Disease or Syndrome" abbrv="">malaria</z:e>, or <z:hpo ids='HP_0012115'>hepatitis</z:hpo> C virus is lower than reported for mixed race or white populations </plain></SENT>
<SENT sid="6" pm="."><plain>aPT were the most prevalent aPL detected in these patient groups, except in patients with <z:e sem="disease" ids="C0023343" disease_type="Disease or Syndrome" abbrv="">leprosy</z:e>, for whom anti-beta(2)GPI was the most prevalent, and where the spectrum of aPL was similar to that seen in patients with SLE and APS </plain></SENT>
</text></document>